Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Inari is a seed design and biotechnology company developing seeds for a nature-positive food system.
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world's most lethal diseases.
Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.
Meiogenix is a biotechnology company that develops breeding technologies.
Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .
Jupiter BioVentures is a creation engine company that focuses on de-risking early-stage projects.
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
CrossBridge Bio operates as a biotechnology company.
Archon is a biotechnology firm that promotes next-generation antibody treatments through AI and computational protein design.
Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs).
Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.
Radiant is a biotechnology company developing the next generation of multi-specificity.
Ability Biologics dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need..
Marvin is made to empower caregivers, leading the global transformation to a modern and sustainable healthcare system.
Delphia Therapeutics operates and manages a laboratory that develops treatments for cancer cells.
5Metis is a new pure-play discovery company for crop health.
Umaro Foods uses green chemistry to unlock value-added ingredients and chemicals from seaweed
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
Cyrus Biotechnology is a developer of Rosetta software platform that solves drug discovery problems.
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
CIBO scales regenerative advanced platform technology that connects growers to incentives and enterprises to growers.
Early stage biotechnology company
Halio is developing adaptive, dynamic glass for the commercial, residential, and automotive markets.
Alexandria Venture Investments has invested in 184 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Alexandria Venture Investments's top investment sectors include Biotechnology, Therapeutics, Health Care, Medical, Life Science. The firm invests across 35 different industry categories.
Among tracked funding rounds, Inari received $144.0M in a Series G round. Alexandria Venture Investments's total known invested capital is $8.0B.
Alexandria Venture Investments's average investment size is $43.4M across its portfolio of 184 companies.
Recent Alexandria Venture Investments portfolio additions include Inari, Ten63 Therapeutics, Pleno, Meiogenix, Valora Therapeutics. These companies were founded in 2020 or later.